Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 12, 2014Journal of Antimicrobial ChemotherapyOpen Access

Measuring trends of outpatient antibiotic use in Europe: jointly modelling longitudinal data in defined daily doses and packages

View Full Paper
Ask AI
Bookmark
Share

Authors

RBRobin BruyndonckxKU LeuvenNHNiel HensUniversity of AntwerpMAMarc AertsHasselt University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bruyndonckx et al. (2014) studied this question.

synapsesocial.com/papers/6a93db4c7fb89795fbfec579https://doi.org/10.1093/jac/dku063
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Application of mixed-effects models to study the country-specific outpatient antibiotic use in Europe: a tutorial on longitudinal data analysis2011 · 27 citations
  2. 2Appropriate international measures for outpatient antibiotic prescribing and consumption: recommendations from a national data comparison of different measures2013 · 56 citations
  3. 3European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe (1997–2009)2011 · 49 citations
  4. 4European Surveillance of Antimicrobial Consumption (ESAC): outpatient use of tetracyclines, sulphonamides and trimethoprim, and other antibacterials in Europe (1997–2009)2011 · 49 citations
  5. 5European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997–2009)2011 · 94 citations